Table of Contents

Biopharmaceuticals, an overview.- Abciximab: The First Platelet Glycoprotein IIb/IIIa Receptor Antagonist.- Recombinant Coagulation Factor IX (BeneFix®).- Biopharmaceutical Drug Development: A Case History.- Follitropin beta (Puregon).- Insulin Lispro (Humalog).- Interferon beta-1b — the first long-term effective treatment of relapsing-remitting and secondary progressive multiple sclerosis (MS).- Reteplase, a recombinant plasminogen activator.- Stabilisation of biopharmaceutical products and finished product formulations.- Patent Law for Biopharmaceuticals.- The development of new medicines: an overview.- The EMEA and regulatory control of (bio)pharmaceuticals within the European Union.- Biopharmaceutical Validation: an overview.- Validation of Biopharmaceutical Chromatography Systems.- Validation of Water for Injections (WFI) for Biopharmaceutical Manufacture.- Information retrieval and the biopharmaceutical industry: an introductory overview.- Information technology and the internet as a resource of biopharmaceutical information.- Marketing Issues for the (Bio)pharmaceutical sector.- Viral mediated gene therapy.- Pharmaceutical gene medicines for non-viral gene therapy.